首页>
外国专利>
DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN.
DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN.
展开▼
机译:包含BI201335,干扰素α和利巴韦林的HCV联合治疗的剂量方案。
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin and particular regimens for administering this combination. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
展开▼